Reduction in levels seen using an intact lipoprotein(a) assay and apolipoprotein(a)-based assay
AHA: Half of U.S. Adults Are Eligible for Treatment With Semaglutide
More than 39 million U.S. adults qualify for indications other than weight management alone
AHA: Tirzepatide Beneficial for Heart Failure With Preserved EF, Obesity
Lower risk for composite of death from cardiovascular causes or worsening heart failure seen with tirzepatide versus placebo
AHA: Initial Catheter Ablation Beneficial for Ventricular Tachycardia
Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy
Considerable Disparities in Life Expectancy Exist Within U.S. Population
Large disparities in life expectancy observed, which grew over time, especially during the first two years of COVID-19
U.S. Overweight, Obesity Rates Set to Continue Increasing to 2050
Total number of children and adolescents with overweight and obesity expected to reach 43.1 million by 2050
Surgeon General Says U.S. Smoking Rates Have Tumbled, But Not for Everyone
By Carole Tanzer Miller HealthDay ReporterWEDNESDAY, Nov. 20, 2024 (HealthDay News) — Although the United States has made significant headway in curbing cigarette smoking and secondhand smoke exposure, a new …
Four Million Americans Could Lose Health Coverage Once ACA Credits Expire
By Carole Tanzer Miller HealthDay ReporterWEDNESDAY, Nov. 20, 2024 (HealthDay News) — If Congress lets health care tax credits established during the pandemic expire, 4 million Americans will become uninsured, …
AHA: Intensive Strategy for Lowering Systolic BP Beneficial in Type 2 Diabetes
Significantly lower incidence of major cardiovascular events seen with intensive- versus standard-treatment strategy
Prevalence of High Total Cholesterol 11.3 Percent in U.S. Adults
Prevalence of low HDL-C was 13.8 percent and was higher in men than women and decreased with age